Healthcare DIVE June 13, 2019
Kristin Jensen

Dive Brief:

  • IBM, Walmart, KPMG and Merck & Co. said the U.S. Food and Drug Administration chose them to be part of a blockchain pilot program designed to track and ensure the integrity of prescription medicines and vaccines.
  • The companies said they expect to complete the program in the fourth quarter of this year, with results slated for publication in an FDA report.
  • Participants “will evaluate next steps” after the conclusion of the pilot, the companies said in a joint statement Thursday.
Dive Insight:

The four industry powerhouses are the latest to tackle the need for an interoperable system that can track and trace medications across the supply...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, FDA, Govt Agencies, Technology
Ethics of Blockchain by Design: Guiding a Responsible Future for Healthcare Innovation
The Blockchain Doesn’t Have To Fix Everything
Quantum-Secure Blockchain: Preparing For The Era Of Quantum Computing
A Pro-Crypto President: What Trump 2.0 Holds for Blockchain’s Future
Blockchain in Healthcare: A Necessary Innovation or a Misguided Panacea?

Share This Article